# MICAFUNGIN IN SODIUM CHLORIDE 0.9%
> **NDA216142** · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2023-09-29
## Drug
- **FDA Application Number:** NDA216142
- **Application type:** New Drug Application
- **Brand name:** MICAFUNGIN IN SODIUM CHLORIDE 0.9%
- **Generic name:** MICAFUNGIN IN SODIUM CHLORIDE
- **Active ingredients:** MICAFUNGIN SODIUM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Corporation
- **First approval:** 2023-09-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216142)
---
*MORVS · CC0 1.0*